1 Min Read
Jan 3 (Reuters) - Abbott Laboratories:
* NEW FDA MR-CONDITIONAL LABELING APPROVALS FURTHER EXPAND ABBOTT‘S PORTFOLIO OF MRI-READY DEVICES Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.